The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma.
 
Thatcher Ross Heumann
No Relationships to Disclose
 
Carol Judkins
No Relationships to Disclose
 
Su Jin Lim
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Rose Parkinson
No Relationships to Disclose
 
Jessica Gai
No Relationships to Disclose
 
Betul Celiker
No Relationships to Disclose
 
Jennifer N. Durham
No Relationships to Disclose
 
Daniel A. Laheru
No Relationships to Disclose
 
Ana De Jesus-Acosta
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Merck (Inst)
 
Dung T. Le
Stock and Other Ownership Interests - Seagen
Honoraria - Merck
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Merck
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Curegenix; Medivir; Merck; Nouscom (Inst)
Patents, Royalties, Other Intellectual Property - Inventor of technology, "Microsatellite Instability as a Pharmacogenomic Marker of Therapeutic Response to Immune Checkpoint Inhibition".
 
Amol Narang
No Relationships to Disclose
 
Robert A Anders
No Relationships to Disclose
 
Kevin Soares
No Relationships to Disclose
 
Richard A. Burkhart
No Relationships to Disclose
 
William Burns
No Relationships to Disclose
 
Elizabeth Thompson
No Relationships to Disclose
 
Jin He
No Relationships to Disclose
 
Elizabeth M. Jaffee
Stock and Other Ownership Interests - ABMETA Therapeutics
Consulting or Advisory Role - Achilles Therapeutics; Adaptive Biotechnologies; Avidea Technologies; CStone Pharmaceuticals; Dragonfly Therapeutics; Genocea Biosciences; Incyte; Medically Home
Research Funding - Aduro Biotech; Amgen; Avidea Technologies; Bristol-Myers Squibb; Corvus Pharmaceuticals; Roche
Patents, Royalties, Other Intellectual Property - I developed GVAX which is being tested in the clinics. It was licensed to Adoro Biotech. IF it becomes commercial I will have the potential to receive royalties. Also, I have received milestone payments yearly.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; CStone Pharmaceuticals; Genocea Biosciences; Medically Home; MedImmune
Other Relationship - Dragonfly Therapeutics
 
Lei Zheng
Stock and Other Ownership Interests - Z and L International Medical
Consulting or Advisory Role - Alphamab; Ambrx; AstraZeneca; Biosynergies; Coherent; datarevive; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Merrimack; Mingruizhiyao; NovaGenesis; novarock
Research Funding - Amgen; AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Gradalis; Halozyme; InxMed; ITeos Therapeutics; Merck; NovaRock
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.